Navigation Links
Bunge Responds to Syngenta Suit
Date:8/23/2011

ST. LOUIS, Aug. 23, 2011 /PRNewswire/ -- Bunge North America, the North American operating arm of Bunge Limited (NYSE: BG), issued the following statement which can be attributed to Soren Schroder, Bunge North America president and CEO.

"Bunge North America is aware from press reports of Syngenta's allegations.  From what we know and from prior conversations with Syngenta, we are surprised and disappointed that Syngenta has taken an action which could put at risk a major export market for U.S. corn producers -- China.

Bunge is a strong proponent of agricultural biotechnology and the benefits it offers to the entire value chain.  We have communicated to Syngenta on several occasions that Bunge looks forward to accepting Agrisure® Viptera™ once approval from China is secured.  We understand that Syngenta expects this will happen in early 2012.

However, until this approval occurs, we must protect the integrity of our export supply chain by not accepting Agrisure Viptera and other varieties that do not have major export market approval.  Our obligation to our farmer customers is to provide access to the global marketplace and the price benefits of that access.  Syngenta's decision to commercialize Agrisure Viptera should not foreclose our ability to sell to a major market – China.

Bunge's decision not to accept Agrisure Viptera is consistent with the North American Export Grain Association's (NAEGA) policy to advocate that technology providers receive all major international approvals for a trait prior to seed sales.  The grain export industry, which includes Bunge, notified Syngenta more than a year ago that China is considered a major export market.

According to the U.S. Department of Agriculture, China is currently the seventh largest destination for U.S. corn with imports expected to grow significantly this year."


'/>"/>
SOURCE Bunge North America
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. SG Biofuels and Bunge Form Strategic Alliance to Process Jatropha Seeds Into Sustainable Crude Oil
2. Bunge Limited to Expand Sugar and Bioenergy Business in Brazil
3. Bunge Limited Schedules Third Quarter 2008 Earnings Release and Conference Call
4. HCCS Responds to Recent Tornados, Earthquakes and Flooding With Free Online Training Course for Disaster Preparedness
5. Virtual reality helps researchers track how brain responds to surroundings
6. Burrill & Company Responds to Recent Press Coverage About Biopark Investment at Elk Run
7. China Biologic Products Responds to Allegations on Financial Websites
8. Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification
9. China Sky One Medical, Inc. Responds to Concerns Regarding Filed Financial Reports
10. Viral Genetics Responds to Rumors of Imminent FDA Filing and Third Party Press Releases
11. Immucor Responds To FDA Notice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... and RESEARCH TRIANGLE PARK, N.C. ... (NASDAQ: UTHR ) announced today that ... of United Therapeutics will provide an overview and update ... st Annual Health Care Conference. The ... at 10:00 a.m. Eastern Time, and can be accessed ...
(Date:4/27/2016)... ... April 27, 2016 , ... PathSensors, Inc., ... Advisory Board. Dr. Lamka will assist PathSensors in expanding the use of the ... deploys the CANARY® test platform for the detection of harmful pathogens, including a ...
(Date:4/27/2016)... ... April 27, 2016 , ... Global Stem Cells Group and ... Symposium as other research and development initiatives for potential stem cell protocol management for ... Stem Cells Group executives began meeting to establish a working agenda and foster initiatives ...
(Date:4/26/2016)... ... April 27, 2016 , ... Cameron ... LLP as an associate in the firm’s Intellectual Property practice group. , Clients ... electromechanical patent applications. He has an electrical engineering and computer engineering background, and ...
Breaking Biology Technology:
(Date:3/9/2016)... 9, 2016 This BCC Research report provides ... the RNA Sequencing (RNA Seq) market for the years ... tools and reagents, data analysis, and services. ... the RNA-Sequencing market such as RNA-Sequencing tools and reagents, ... factors affecting each segment and forecast their market growth, ...
(Date:3/8/2016)... , March 8, 2016   Valencell ... technology, today announced it has secured $11M in ... GII Tech, a new venture fund being launched ... additional participation from existing investors TDF Ventures and ... funds to continue its triple-digit growth and accelerate ...
(Date:3/3/2016)... and DE SOTO, Kansas , March ... Detection Plus® to offer Oncimmune,s Early CDT®-Lung, a ... early detection of lung cancer Early CDT®-Lung ... and individuals. --> Early CDT®-Lung test to ... --> Oncimmune, a leader in early cancer ...
Breaking Biology News(10 mins):